Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Restructuring Costs (2022 - 2025)

Standard Biotools (LAB) has disclosed Restructuring Costs for 5 consecutive years, with $11.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Restructuring Costs rose 121.17% to $11.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.1 million, a 25.59% decrease, with the full-year FY2024 number at $12.5 million, up 76.65% from a year prior.
  • Restructuring Costs was $11.2 million for Q3 2025 at Standard Biotools, up from -$78000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $11.2 million in Q3 2025 to a low of -$634000.0 in Q3 2023.
  • A 4-year average of $3.1 million and a median of $2.5 million in 2023 define the central range for Restructuring Costs.
  • Peak YoY movement for Restructuring Costs: surged 901.1% in 2024, then crashed 102.8% in 2025.
  • Standard Biotools' Restructuring Costs stood at $4.6 million in 2022, then increased by 16.8% to $5.4 million in 2023, then plummeted by 93.44% to $355000.0 in 2024, then skyrocketed by 3064.23% to $11.2 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Restructuring Costs are $11.2 million (Q3 2025), -$78000.0 (Q2 2025), and $1.6 million (Q1 2025).